LabMed
Secondary Hypoaldosteronism (Hyporeninemic Hypoaldosteronism)
-
At a Glance
-
What Tests Should I Request to Confirm My Clinical Dx? In addition, what follow-up tests might be useful?
-
Are There Any Factors That Might Affect the Lab Results? In particular, does your patient take any medications - OTC drugs or Herbals - that might affect the lab results?
-
What Lab Results Are Confirmatory?
-
What Tests Should I Request to Confirm My Clinical Dx? In addition, what follow-up tests might be useful?
At a Glance
Hyperkalemia and hyperchloremic metabolic acidosis in patients with chronic kidney disease should lead to suspicion of secondary hypoaldosteronism. The juxtaglomerular apparatus in the kidney is the source of production of renin. Consequently, injury to the juxtaglomerular apparatus in kidney disease can impair the production of renin and decrease activation of the renin-angiotensin-aldosterone system. Impaired renin production leads to hypoaldosteronism. (See the chapter on primary hypoaldosteronism.) This disorder is often overlooked because affected patients have kidney disease and other disease processes. Renal injury leading to decreased renin production may be from a variety of causes, including diabetes, obstructive nephropathy, chronic pyelonephritis, analgesic nephropathy, sickle cell disease, and lead nephropathy.
What Tests Should I Request to Confirm My Clinical Dx? In addition, what follow-up tests might be useful?
Electrolyte analysis shows increased potassium, usually with a metabolic acidosis without an increased anion gap. Plasma aldosterone and renin are decreased, although aldosterone release is usually stimulated by hyperkalemia. The plasma aldosterone:renin ratio is often within the normal range (
Table 1.
Test Results Indicative of the Disorder
Serum Potassium | Renin | Aldosterone |
---|---|---|
High | Low | Low |
Are There Any Factors That Might Affect the Lab Results? In particular, does your patient take any medications - OTC drugs or Herbals - that might affect the lab results?
A number of factors can lead to factitiously high measured serum potassium. Excessive tourniquet time or fist-clenching during specimen collection can lead to increases in serum potassium. Hemolysis of specimens and prolonged storage of serum on the clot can increase serum potassium. High platelet counts increase serum potassium because of release of potassium from platelets during specimen clotting.
Renin production is inhibited by a number of medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), beta blockers, clonidine, and alpha-methyldopa. Renin production is normally suppressed by volume overload and sodium loading and by a recumbent posture. Renin production is increased by volume depletion, upright posture, and diuretics.
This disorder can be exacerbated by a variety of drugs, including NSAIDs, beta-blockers, and potassium-sparing diuretics.
What Lab Results Are Confirmatory?
Measurement of aldosterone and renin in specimens collected in an upright position or after administration of furosemide will usually not show stimulation. Response of aldosterone to adrenocorticotropic hormone (ACTH) stimulation is usually diminished.
What Tests Should I Request to Confirm My Clinical Dx? In addition, what follow-up tests might be useful?
Measurement of serum creatinine or other measures of renal function will show indications of renal injury.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
ONA Articles
- Takeda to Collaborate With MSKCC on CAR-T Therapies for Multiple Myeloma
- Shorter Duration of Cryotherapy as Effective as Standard Therapy Prior to HSCT for Multiple Myeloma
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- Sequential Immunotherapy, Targeted Therapy Linked to Cutaneous Adverse Events in Advanced Melanoma
- 9/11 Responders May Have Higher Head and Neck Cancer Risk
- Oncology Nurse Navigation Facilitates Timely Treatment of Pancreatic Cancer
- Helping Patients Face the Challenge of Eating Healthy During Cancer Treatment
- Oncology Nurses Weigh In on Their Patient-Centered Communication Practices, Needs
- Substitute for Lidocaine
- CART cell therapy for prostate cancer: status and promise
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- Survey Demonstrates Relationship Between Symptom Burden, Medical Disability Leave Among Myeloproliferative Neoplasms
- A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- USPSTF Still Recommends Against Pancreatic Cancer Screening
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
Bone Cancer | Regimens | Drugs |
Brain Cancer | Regimens | Drugs |
Breast Cancer | Regimens | Drugs |
Endocrine Cancer | Regimens | Drugs |
Gastrointestinal Cancer | Regimens | Drugs |
Genitourinary Cancer | Regimens | Drugs |
Gynecologic Cancer | Regimens | Drugs |
Head and Neck Cancer | Regimens | Drugs |
Hematologic Cancer | Regimens | Drugs |
Lung Cancer | Regimens | Drugs |
Other Cancers | Regimens | |
Rare Cancers | Regimens | |
Skin Cancer | Regimens | Drugs |